Victoria J. Tear, PhD

VP Non-Clinical Operations
Synairgen Research Limited
Southampton, England, United Kingdom

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB1533 - Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial

  Friday, October 21, 2022
  2:35 PM – 2:45 PM US ET